A. Taveira-DaSilva

发表

CT grading of lung disease in lymphangioleiomyomatosis.

Jianhua Yao, T. Colby, J. Moss, 2012, AJR. American journal of roentgenology.

Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis

Jianhua Yao, Joel Moss, Nilo A. Avila, 2019, Chest.

Severity and outcome of cystic lung disease in women with tuberous sclerosis complex

Jianhua Yao, J. Moss, M. Stylianou, 2015, European Respiratory Journal.

Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.

Jianhua Yao, J. Moss, M. Stylianou, 2014, American journal of respiratory and critical care medicine.

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

G. Beck, T. Raffin, Jar‐Chi Lee, 2006, American journal of respiratory and critical care medicine.

The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

J. Moss, A. Taveira-DaSilva, G. Pacheco-Rodríguez, 2010, Lymphatic research and biology.

Functional Genomics of Lung Disease

S. Redline, N. Friedman, A. Regev, 2004 .

Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.

Vandana Sachdev, Mark T Gladwin, M. Gladwin, 2007, American journal of respiratory and critical care medicine.

Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

J. Moss, M. Moses, Connie G. Glasgow, 2010, Respiratory medicine.

Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2011, Annals of internal medicine.

Prevalence of uterine leiomyomas in lymphangioleiomyomatosis.

J. Moss, A. Taveira-DaSilva, N. Avila, 2011, Fertility and sterility.

Meningiomas in lymphangioleiomyomatosis.

N. Patronas, J. Moss, Joel Moss, 2001, JAMA.

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial

D. Bienfang, E. Henske, J. Moss, 2017, Chest.

Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2011, American journal of physiology. Lung cellular and molecular physiology.

Lymphangioleiomyomatosis Diagnosis and Management: High‐Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline

Meilan K. Han, C. Strange, S. Sahn, 2017, American journal of respiratory and critical care medicine.

Bone mineral density in lymphangioleiomyomatosis.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2005, American journal of respiratory and critical care medicine.

Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.

J. Moss, M. Stylianou, A. Taveira-DaSilva, 2015, Chest.

Progress in the treatment of lymphangioleiomyomatosis: from bench to bedside.

J. Moss, A. Taveira-DaSilva, 2012, Revista portuguesa de pneumologia.

Optimizing treatments for lymphangioleiomyomatosis

J. Moss, A. Taveira-DaSilva, 2012, Expert review of respiratory medicine.

Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis

H. Wen, M. Pirooznia, J. Moss, 2021, Chest.

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

Olanda M. Hathaway, J. Moss, V. Sachdev, 2007, Chest.

Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts

J. Moss, M. Stylianou, Simon R. Johnson, 2020, Thorax.

Pathophysiology of Lymphangioleiomyomatosis

E. Henske, J. Moss, S. El-Chemaly, 2021 .

The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15‐Year Prospective Longitudinal Analysis

G. Beck, Hye-Seung Lee, J. Moss, 2019, Chest.

Long‐Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis

J. Moss, M. Stylianou, A. Taveira-DaSilva, 2018, Chest.

Incidence of Pneumothorax in Patients With Lymphangioleiomyomatosis Undergoing Pulmonary Function and Exercise Testing.

J. Moss, A. Taveira-DaSilva, P. Julien‐Williams, 2016, Chest.

Effect of fasting on the size of lymphangioleiomyomas in patients with lymphangioleiomyomatosis.

T. Shawker, J. Moss, M. Stylianou, 2015, Chest.

Involvement of lymphatics in lymphangioleiomyomatosis.

J. Moss, S. El-Chemaly, Xiong Cai, 2009, Lymphatic research and biology.

Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis.

Olanda M. Hathaway, J. Moss, J. Fontana, 2009, Chest.

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going

J. Moss, A. Taveira-DaSilva, W. Steagall, 2009, F1000 medicine reports.

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

J. Moss, S. Harari, I. Chiodini, 2008, Chest.

Lymphatic Involvement in Lymphangioleiomyomatosis

J. Moss, T. Darling, A. Taveira-DaSilva, 2008, Annals of the New York Academy of Sciences.

Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis.

Olanda M. Hathaway, J. Moss, Jing-Ping Lin, 2007, American journal of physiology. Lung cellular and molecular physiology.

Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.

W. Travis, V. Ferrans, J. Moss, 2001, American journal of respiratory and critical care medicine.

Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2004, Chest.

Basic Fibroblast Growth Factor Increases Long-Term Survival of Spinal Motor Neurons and Improves Respiratory Function after Experimental Spinal Cord Injury

J. Wrathall, R. Gillis, Y. Teng, 1999, The Journal of Neuroscience.

Metabolic Changes in Lymphangioleiomyomatosis Patients Treated with Sirolimus and Hydroxychloroquine.

E. Henske, J. Moss, Yan Tang, 2019, Chest.

Metabolic Changes in Lymphangioleiomyomatosis Patients Treated with Sirolimus and Hydroxychloroquine.

E. Henske, J. Moss, Yan Tang, 2019, Chest.

Statins in lymphangioleiomyomatosis: a word of caution

J. Moss, M. Stylianou, S. El-Chemaly, 2009, European Respiratory Journal.

Increased consumption and vasodilatory effect of nitrite during exercise.

Elaina E. Lin, M. Gladwin, He Sun, 2016, American journal of physiology. Lung cellular and molecular physiology.

Serotonin 1A Receptor Agonists Reverse Respiratory Abnormalities in Spinal Cord-Injured Rats

J. Wrathall, R. Gillis, Y. Teng, 2003, The Journal of Neuroscience.

Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features

Ellen F. Macnamara, W. Gahl, T. Markello, 2018, Journal of Medical Genetics.

Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation

Marcus Y. Chen, Joel Moss, A. Taveira-DaSilva, 2022, BMC Pulmonary Medicine.

Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study

H. Wen, M. Pirooznia, J. Moss, 2021, European Respiratory Journal.

INTERSTITIAL LUNG DISEASE | Lymphangioleiomyomatosis

J. Moss, A. Taveira-DaSilva, W. Steagall, 2006 .

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

J. Krischer, Hye-Seung Lee, L. Korbee, 2011, The New England journal of medicine.

Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis

J. Moss, A. Taveira-DaSilva, 2016, Expert opinion on orphan drugs.

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Bruce Barton, Myron Waclawiw, Vandana Sachdev, 2006, JAMA.

Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors.

N. Sahibzada, R. Gillis, A. Taveira-DaSilva, 2000, The Journal of pharmacology and experimental therapeutics.

Management of lymphangioleiomyomatosis

J. Moss, A. Taveira-DaSilva, 2014, F1000prime reports.

Mounier-Kuhn Syndrome Mimicking Lymphangioleiomyomatosis.

Jianhua Yao, J. Moss, D. Kleiner, 2018, Chest.

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

J. Moss, A. Taveira-DaSilva, 2015, Clinical epidemiology.

Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis

J. Krischer, Hye-Seung Lee, C. Strange, 2019, European Respiratory Journal.

Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis

E. Henske, J. Moss, I. Rosas, 2018, Chest.

Addressing the challenges of lymphangioleiomyomatosis assessment in the clinic

J. Moss, A. Taveira-DaSilva, 2017 .

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

J. Brożek, J. D’Armiento, C. Strange, 2016, American journal of respiratory and critical care medicine.

Of ﬁ cial American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management

J. Brożek, C. Strange, S. Sahn, 2016 .

Of fi cial American Thoracic Society / Japanese Respiratory Society Clinical Practice Guidelines : Lymphangioleiomyomatosis Diagnosis and Management

J. Brożek, C. Strange, S. Sahn, 2016 .

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.

Charlie Strange, Joel Moss, Yoshikazu Inoue, 2013, The Lancet. Respiratory medicine.

Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.

W. Travis, J. Moss, M. Stylianou, 2003, American journal of respiratory and critical care medicine.

Favorable Response to Antigonadal Therapy for a Benign Metastasizing Leiomyoma

E. Levens, J. Moss, A. Taveira-DaSilva, 2012, Obstetrics and gynecology.

Benign Metastasizing Leiomyoma.

J. Moss, A. Taveira-DaSilva, G. Pacheco‐Rodriguez, 2016, Clinics in chest medicine.

Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.

J. Moss, S. Harari, A. Taveira-DaSilva, 2012, Respiratory medicine.

Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial

D. Kwiatkowski, E. Henske, J. Moss, 2020, European Respiratory Journal.

Reversible airflow obstruction in lymphangioleiomyomatosis.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2009, Chest.

Rates of change in FEV1 and DLCO as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients

J. Moss, M. Stylianou, A. Taveira-DaSilva, 2018, European Respiratory Journal.

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

A. Taveira-DaSilva, J. Moss, Pulmonary Branch, 2015 .

Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.

Olanda M. Hathaway, J. Moss, M. Stylianou, 2011, Annals of internal medicine.

Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells

E. Henske, C. Priolo, S. El-Chemaly, 2019 .